Cargando…

The total hospital and community UK costs of managing patients with relapsed breast cancer

The complete hospital and community records of 77 women were randomly selected from 232 women who had relapsed breast cancer between 2000 and 2005. Scrutiny of all management activities revealed a total cost of £1 939 329 (mean per patient of £25 186, 95% CI £13 705–£33 821). The median survival fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, R J, Williams, M, Marshall, C, Glen, J, Callam, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653736/ https://www.ncbi.nlm.nih.gov/pubmed/19223909 http://dx.doi.org/10.1038/sj.bjc.6604911

Ejemplares similares

Cost-benefit of COVID-19 lockdown in the UK
Publicado: (2020)

Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysis
por: Karnon, J, et al.
Publicado: (2007)

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience
por: Montgomery, D A, et al.
Publicado: (2007)

Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997–2003
por: Caldon, L J M, et al.
Publicado: (2005)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
por: Howell, S J, et al.
Publicado: (2009)

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years
por: Lavelle, K, et al.
Publicado: (2007)

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)
por: Liniker, E, et al.
Publicado: (2013)

Cost-Effectiveness of Total Colonoscopy in Screening of Colorectal Cancer in Japan
por: Sekiguchi, Masau, et al.
Publicado: (2012)

The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology
por: Swerdlow, A J, et al.
Publicado: (2011)

Breast Cancer Treatment Practices in Elderly Women in a Community Hospital
por: Wang, Hua, et al.
Publicado: (2011)

Childhood febrile illness and the risk of myopia in UK Biobank participants
por: Guggenheim, J A, et al.
Publicado: (2016)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
por: Stephen, J, et al.
Publicado: (2014)

Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme
por: Dibden, A, et al.
Publicado: (2014)

Fasciola hepatica in UK horses
por: Howell, A. K., et al.
Publicado: (2019)

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007)

Medical student teaching in the UK: how well are newly qualified doctors prepared for their role caring for patients with cancer in hospital?
por: Cave, J, et al.
Publicado: (2007)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment
por: Generali, D, et al.
Publicado: (2014)

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers
por: Croshaw, Randal L., et al.
Publicado: (2011)

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
por: Toi, M, et al.
Publicado: (2009)

Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience − A Multicenter Retrospective Study
por: Jafri, Mariam, et al.
Publicado: (2022)

The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer
por: Day, R S, et al.
Publicado: (2005)

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
por: Campbell, H E, et al.
Publicado: (2010)

Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study
por: Lavelle, K, et al.
Publicado: (2014)

Cancer of the breast: 5-year survival in a tertiary hospital in Uganda
por: Gakwaya, A, et al.
Publicado: (2008)

Trends in UK cancer trials: results from the UK Coordinating Committee for Cancer Research National Register of Cancer Trials
por: Vale, C, et al.
Publicado: (2005)

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers
por: Wu, C, et al.
Publicado: (2015)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

Measures of socioeconomic status and self-reported glaucoma in the UK Biobank cohort
por: Shweikh, Y, et al.
Publicado: (2015)

Experience of symptoms indicative of gynaecological cancers in UK women
por: Low, E L, et al.
Publicado: (2013)

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
por: McCowan, C, et al.
Publicado: (2013)

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
por: Younes, A, et al.
Publicado: (2010)

Familial breast cancer: management of ‘lower risk’ referrals
por: Young, D, et al.
Publicado: (2006)

Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project
por: Dodwell, D, et al.
Publicado: (2007)

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
por: Gallego, Oscar, et al.
Publicado: (2013)

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
por: Ng, M, et al.
Publicado: (2005)

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
por: Sabel, Magnus, et al.
Publicado: (2016)

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
por: Rossi, J-F, et al.
Publicado: (2009)

Digital Breast Tomosynthesis Changes Management in Patients Seen at a Tertiary Care Breast Center
por: Margolies, L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l2k9bp0c2qcfh7vg95vl2hld1l